Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 1012
Aptamer sequence: ATCCAGAGTGACGCAGCACACCGTTTGTATTCTGCATTGTTTTGCATTCTACATGGACACGGTGGCTTAGT
Target unique ID: Other-33
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_922 PP2 Other Glycosylated Hemagglutinin of Vaccinia Virus-Infected Cells 122.63 nM 4.5 g/L glucose and 5 mM MgCl2 in Dulbecco’s PBS (Sigma), BSA (1 mg/mL from Fisher) with t-RNA (0.1 mg/mL) 20873781
Structure information of aptamer
Aptamer Sequence: ATCCAGAGTGACGCAGCACACCGTTTGTATTCTGCATTGTTTTGCATTCTACATGGACACGGTGGCTTAGT
The optimal secondary structure in dot-bracket notation: ..........((..(((.((((((.((((...((((......))))...)))).....)))))))))..))
The centroid secondary structure in dot-bracket notation: ..........((..(((.((((((.((((...((((......))))...)))).....)))))))))..))
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_922 Description PP2
Aptamer chemistry DNA Length 71 nt
GC content 46.5% Molecular weight 21,855.99 Da
Molarity of 1 μg/μl solution 45.75 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Target recognition
Sequence ATCCAGAGTGACGCAGCACACCGTTTGTATTCTGCATTGTTTTGCATTCTACATGGACACGGTGGCTTAGT
Applications Recognize proteins expressed on the surface of VV-infected cells
Target information
Type Detail Type Detail
Target ID Other-33 Name Glycosylated Hemagglutinin of Vaccinia Virus-Infected Cells
Activity data
Interaction ID 1012
Target type Other
Target unique ID Other-33
Activity 122.63 nM
Binding Conditions/Buffer

4.5 g/L glucose and 5 mM MgCl2 in Dulbecco’s PBS (Sigma), BSA (1 mg/mL from Fisher) with t-RNA (0.1 mg/mL)

Assay

Individual aptamers tested against infected and uninfected cells. (A) VV Infected HeLa cells treated with FITC-labeled aptamer PP2

PubMed ID 20873781
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_921 DNA ATCCAGAGTGACGCAGCACGAGCCAGACATCTCACACCTGTTGCATATACATTTTGCATGGACACGGTGGCTTAGT 75.00%
Apta_923 DNA ATCCAGAGTGACGCAGCATCGACCTCTGTGCGAGCGGGTTGCATATATATTTTGCATGGACACGGTGGCTTAGT 74.32%
Apta_785 DNA ATCCAGAGTGACGCAGCATGAATCTTTTCTTTTGGTTTTGATATTTATAGTTGGTGAATGGACACGGTGGCTTAGT 73.68%
Apta_786 DNA ATCCAGAGTGACGCAGCATTTGTATCCTATTTTGTTTATGTAATTGTCGTTGATCATGTGGACACGGTGGCTTAGT 73.68%
Apta_401 DNA ATCCAGAGTGACGCAGCAGATAAGTAGGTATCCGTTTGAAAAACTTTTCTGACCGTCCGACTATGGACACGGTGGCTTAGT 71.60%
Apta_725 DNA ATCCAGAGTGACGCAGCATGCTCATCCACGATTCTGGCGAATTTAGTGCCTGTCTTTTTCTCTTGGACACGGTGGCTTAGT 71.60%
Apta_1088 DNA ATCCAGAGTGACGCAGCATCGAGTGGCTTGTTTGTAATGTAGGGTTCCGGTCGTGGGTTGGACACGGTGGCTTAGT 71.05%
Apta_1089 DNA ATCCAGAGTGACGCAGCAATTACCGATGGCTTGTTTGTAATGTAGGGTTCCGTCGGATTGGACACGGTGGCTTAGT 71.05%
Apta_1293 DNA ATCCAGAGTGACGCAGCATGCCCTAGTTACTACTACTCTTTTTAGCAAACGCCCTCGCTTTGGACACGGTGGCTTAGT 70.51%
Apta_794 DNA ATCCAGAGTGACGCAGCAAGGAGATTCGAGGGGGAAGGTTTGTTATAGGGGTTAATGGACACGGTGGCTTAGT 69.86%
Apta_784 DNA ATCCAGAGTGACGCAGCATTTTGACGCTTTATCCTTTTCTTATGGCGGGATAGTTTCGTGGACACGGTGGCTTAGT 69.74%
Apta_1090 DNA ATCCAGAGTGACGCAGCAGGGCTTGGGTTGGGAATAAGGATGTGGGAGGCGGCGAACATGGACACGGTGGCTTAGT 69.74%
Apta_787 DNA ATCCAGAGTGACGCAGCATTTGTTTAATATGTTTTTTAATTCCCCTTGTGGTGTGTTGTGGACACGGTGGCTTAGT 68.42%
Apta_920 DNA ATCCAGAGTGACGCAGCACGGCACTCACTCTTTGTTAAGTGGTCTGCTTCTTAACCTTCATCGACACGGTGGCTTA 67.11%
Apta_734 DNA TCCTCGATGCACCAGTTCACCTTATTTGCTTCTTCTCTCTGTTCTGACTGGGTGCTGAGGA 59.15%
Apta_1112 DNA ATCCAGAGTGACGCAGCAGGGCACATTGTTCACACACAGATCACATTACGGAAAACACAACTACACGAAATGTCGTTGGTGGCCC 55.29%
Apta_1099 DNA ATCCATTGCCACTGACTACCAGCCGGGTGGGTGGGGGGGTTTGCTGGTATCGCATTGTGCGAAGTCAGTCGGTCGTTAGT 55.00%
Apta_288 DNA ATCCAGAGTGACGCAGCATTTCATCGGGTCCAAAAGGGGCTGCTCGGGATTGCGGATATGGACACGT 54.93%
Apta_1180 DNA GAATTCAGTCGGACAGCGCAATTGTGGTTCTTACCCTATCCCTTGTGTTTGGCGTTCGTTGCGATGGACGAATATCGTCTCCC 54.22%
Apta_174 DNA AGCAGCACAGAGGTCAGATGTCGGTCTTGTGTATACATACCCGTGTGTTTTCATCTCAGGCCTATGCGTGCTACCGTGAA 53.75%